The Leukemia & Lymphoma Society 2025 Research Grants Include Acute Leukemia in Children with Down Syndrome Thumbnail Image Read more about The Leukemia & Lymphoma Society 2025 Research Grants Include Acute Leukemia in Children with Down Syndrome
The Leukemia & Lymphoma Society Announces Reimagined Executive Leadership Team Thumbnail Image Read more about The Leukemia & Lymphoma Society Announces Reimagined Executive Leadership Team
Valvoline™ Global Operations Announces Major Commitment to The Leukemia & Lymphoma Society to Power Better Treatments for Kids with Blood Cancer Worldwide Thumbnail Image Read more about Valvoline™ Global Operations Announces Major Commitment to The Leukemia & Lymphoma Society to Power Better Treatments for Kids with Blood Cancer Worldwide
Blood Cancer Foundations Award $2.25 Million for ‘Research United to CURE Follicular Lymphoma’ Thumbnail Image Read more about Blood Cancer Foundations Award $2.25 Million for ‘Research United to CURE Follicular Lymphoma’
The Immune System and Blood Cancer: 4 Things You Need to Know By Lee Greenberger, Ph.D., LLS Chief Scientific Officer | June 27, 2024 Read More
14-Year-Old High School Students from Los Angeles Earn The Leukemia & Lymphoma Society’s (LLS) 2024 National Student Visionaries of the Year Title Thumbnail Image Read more about 14-Year-Old High School Students from Los Angeles Earn The Leukemia & Lymphoma Society’s (LLS) 2024 National Student Visionaries of the Year Title
New $20 Million Research Funding Program Aims to ‘Accelerate a Cure’ for Follicular Lymphoma Thumbnail Image Read more about New $20 Million Research Funding Program Aims to ‘Accelerate a Cure’ for Follicular Lymphoma
Breaking Data Presented at ASCO 2024 Showcase Breadth of The Leukemia & Lymphoma Society Therapy Acceleration Program Impact on Key Blood Cancer Research Thumbnail Image Read more about Breaking Data Presented at ASCO 2024 Showcase Breadth of The Leukemia & Lymphoma Society Therapy Acceleration Program Impact on Key Blood Cancer Research
FDA’s ODAC Endorses New Indications for 2 CAR-T Therapies for Myeloma Thumbnail Image Read more about FDA’s ODAC Endorses New Indications for 2 CAR-T Therapies for Myeloma
Bringing Light to The Darkness of Cancer: BeiGene Named National Partner of Survivorship and Hope for The Leukemia & Lymphoma Society’s Light The Night Read more about Bringing Light to The Darkness of Cancer: BeiGene Named National Partner of Survivorship and Hope for The Leukemia & Lymphoma Society’s Light The Night
